Skip to main content
. 2022 Dec 3;20:560. doi: 10.1186/s12967-022-03719-7

Fig. 2.

Fig. 2

The predicted 10-year survival in female cancer patients with different time intervals to treatment. A stage I NSCLC, B stage II NSCLC, C stage I infiltrating breast cancer, D stage II infiltrating breast cancer, NSCLC non-small cell lung cancer